Medtronic is recalling seven of its implantable cardioverter defibrillators and cardiac resynchronization therapy devices due to an unexpected and rapid decrease in battery life. FDA said there have been 444 complaints about the devices, and 264 reports, with 18 injuries including people experiencing heart rhythm or heart failure symptoms.
Related Articles